<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2" exact="infection" post="FantiniJacquesjacques.fantini@univ-amu.frab⁎Di ScalaCoraliecChahinianHenriabYahiNouaraab[a], [b], [c], ⁎Corresponding author. Address: INSERM UMR_S"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="for infected patients without delay. The first step of the" exact="viral" post="replication cycle [i.e. attachment to the surface of respiratory"/>
 <result pre="the viral replication cycle [i.e. attachment to the surface of" exact="respiratory" post="cells, mediated by the spike (S) viral protein] offers"/>
 <result pre="the surface of respiratory cells, mediated by the spike (S)" exact="viral" post="protein] offers several potential therapeutic targets. The S protein"/>
 <result pre="of CLQ [or its more active derivative, hydroxychloroquine (CLQ-OH)], the" exact="viral" post="S protein is no longer able to bind gangliosides."/>
 <result pre="it has shown apparent efficacy in the treatment of COVID-19-associated" exact="pneumonia" post="in recent clinical studies [4]. However, the mechanism of"/>
 <result pre="the interesting and mostly unexplored possibility that CLQ could prevent" exact="viral" post="attachment through a direct effect on host cell surface"/>
 <result pre="also depend upon sialic-acid-containing glycoproteins and gangliosides that act as" exact="primary" post="attachment factors along the respiratory tract [10]. The present"/>
 <result pre="and gangliosides that act as primary attachment factors along the" exact="respiratory" post="tract [10]. The present study used a combination of"/>
 <result pre="S–ganglioside interaction which occurs in the first step of the" exact="viral" post="replication cycle (i.e. attachment to the surface of respiratory"/>
 <result pre="the viral replication cycle (i.e. attachment to the surface of" exact="respiratory" post="cells, mediated by the S protein). In addition, the"/>
 <result pre="In the next step, the ganglioside was included in a" exact="periodic" post="box solvated with 1128 water molecules. The system was"/>
 <result pre="field optimized for carbohydrates [17]. Interaction energies were calculated from" exact="stable" post="complexes using the Ligand Energy Inspector function of Molegro"/>
 <result pre="CLQ-OH may adopt a wide range of conformations, the most" exact="stable" post="being the extended one shown in Fig. 1(c). When"/>
 <result pre="extended one shown in Fig. 1(c). When immersed in a" exact="periodic" post="box of 31.5 Å2 with 1042 water molecules, the"/>
 <result pre="Molecular recognition of gangliosides by CLQ and CLQ-OH In the" exact="respiratory" post="tract, sialic acids are usually part of glycoproteins and"/>
 <result pre="S proteins, each harbouring two distinct domains distant from the" exact="viral" post="envelope: the receptor-binding region (RBD) and the NTD. Fig."/>
 <result pre="Overall, the complex involved 10 amino acid residues for a" exact="total" post="energy of interaction of -100 kJ.mol−1. At this stage,"/>
 <result pre="Asn‐137 −15.2 Asp‐138 −6.4 Arg‐158 −17.4 Ser‐161 −9.7 Ser‐162 −2.0" exact="Total" post="−100.2 Second step: two GM1 molecules Asp‐111 −15.8 Ser‐112"/>
 <result pre="Phe‐157 −13.8 Arg‐158 −19.8 Tyr‐160 −3.2 Ser‐161 −9.7 Ser‐162 −2.0" exact="Total" post="−136.6 Fig. 7 Molecular complex between the N-terminal domain"/>
 <result pre="and angiotensin-converting enzyme-2 (ACE-2) by SARS-CoV-2 spike (S) protein. The" exact="viral" post="protein displays two distinct domains, the tips of which"/>
 <result pre="blue), provide a perfect attractive interface for adequately positioning the" exact="viral" post="S protein at the first step of the infection"/>
 <result pre="the viral S protein at the first step of the" exact="infection" post="process. These structural and molecular modelling studies suggest that"/>
 <result pre="position when bound to GM1, so GM1 cannot bind the" exact="viral" post="protein and the drug simultaneously. This is due to"/>
 <result pre="entry [10]. These viruses include major human pathogens affecting the" exact="respiratory" post="tract, such as influenza [21] and coronaviruses [22,23]. The"/>
 <result pre="structures is mediated by receptor-binding proteins that belong to the" exact="viral" post="spike. In the case of coronaviruses, this function is"/>
 <result pre="to ACE-2 alone might not be enough to ensure robust" exact="infection" post="of the upper respiratory tract. Thus, it is likely"/>
 <result pre="might not be enough to ensure robust infection of the" exact="upper" post="respiratory tract. Thus, it is likely that SARS-CoV-2 might"/>
 <result pre="not be enough to ensure robust infection of the upper" exact="respiratory" post="tract. Thus, it is likely that SARS-CoV-2 might also"/>
 <result pre="conferred an enhanced attachment capacity of human coronaviruses to the" exact="respiratory" post="tract through improved S–ganglioside interactions. 5 Conclusion Given the"/>
 <result pre="interfere with the initial attachment of virus particles to the" exact="respiratory" post="tract surface epithelium. The study data support the use"/>
 <result pre="initial therapy for patients infected with SARS-CoV-2. References References 1ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends2020 Feb 1910.5582/bst.2020.01047[Epub ahead of print]"/>
 <result pre="decreasing autophagosome–lysosome fusionAutophagy1420181435145529940786 7VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.Chloroquine is a potent inhibitor of SARS" exact="coronavirus infection" post="and spreadVirol J220056916115318 8LiW.MooreM.J.VasilievaN.SuiJ.WongS.K.BerneM.A.Angiotensin-converting enzyme 2 is a functional"/>
 <result pre="autophagosome–lysosome fusionAutophagy1420181435145529940786 7VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J220056916115318 8LiW.MooreM.J.VasilievaN.SuiJ.WongS.K.BerneM.A.Angiotensin-converting enzyme 2 is a functional"/>
 <result pre="print] 25LiW.HulswitR.J.G.WidjajaI.RajV.S.McBrideR.PengW.Identification of sialic acid-binding function for the Middle East" exact="respiratory" post="syndrome coronavirus spike glycoproteinProc Natl Acad Sci USA1142017E8508E851728923942 26FantiniJ.YahiN.Molecular"/>
 <result pre="25LiW.HulswitR.J.G.WidjajaI.RajV.S.McBrideR.PengW.Identification of sialic acid-binding function for the Middle East respiratory" exact="syndrome" post="coronavirus spike glycoproteinProc Natl Acad Sci USA1142017E8508E851728923942 26FantiniJ.YahiN.Molecular insights"/>
 <result pre="pylori to gastrointestinal cellsBiochemistry452006109571096216953581 29FantiniJ.YahiN.Brain lipids in synaptic function and" exact="neurological disease." post="Clues to innovative therapeutic strategies for brain disorders2015ElsevierSan Francisco"/>
 <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 Mar 910.1093/cid/ciaa237pii:ciaa237"/>
 <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 Mar 910.1093/cid/ciaa237pii:ciaa237 Funding:"/>
 <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 Mar 910.1093/cid/ciaa237pii:ciaa237 Funding: None."/>
</results>
